ArticleInfectious diseases and therapy2026
Mass Gatherings as Amplifiers of Meningococcal Disease: A Modeling Study of Hajj and Umrah.
Article in Infectious diseases and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Kingdom of Saudi Arabia (KSA) hosts millions of Hajj and Umrah pilgrims annually, and it aims to welcome 30 million external (international) Umrah pilgrims annually by 2030 (Saudi Vision 2030). These mass gatherings pose significant risks for infectious disease transmission. We extended a previous meta-population model of Neisseria meningitidis transmission during Hajj to include Umrah pilgrimage and assessed the impact of varying vaccination coverage rates (VCRs) among pilgrims on meningococcal meningitis (MM) cases.
methodsThe model population was divided into five clusters: residents of the pilgrimage sites (Makkah/Madinah); the broader KSA population; and non-KSA populations from high-, medium-, and low-transmission settings. The model incorporated age, pilgrim movement patterns, and VCRs. The model was calibrated with data from 1995 to 2011 and validated with data from 2012 to 2024. MM cases under various vaccination and pilgrim scenarios were simulated for the 2025-2034 period.
resultsUmrah accounted for approximately 90% of pilgrimage days in 2023-2024, with external pilgrims accounting for > 90% of these days. In a scenario where external pilgrim numbers increased in line with Saudi Vision 2030, the probability of an annual number of MM cases exceeding 100 among pilgrims during the 2025-2034 period was estimated at 53% with a 10% VCR among internal (domestic) and external Umrah pilgrims versus < 0.02% if both VCRs were 90%. High VCRs (90%) for external and internal pilgrims reduced the number of expected MM cases across the KSA by > 80% compared with no vaccination.
conclusionOur analysis highlights the amplifying effect of mass gatherings on disease transmission dynamics and confirms vaccination as a highly effective intervention. Strengthened enforcement of meningococcal ACWY vaccination requirements for all Umrah pilgrims would significantly reduce MM outbreak risk and benefit the entire KSA population, as well as the pilgrims and people in their countries of origin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.